110 results
8-K
EX-99.1
RGEN
Repligen Corp.
1 May 24
Repligen Reports First Quarter 2024 Financial Results
7:44am
and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We
8-K
EX-99.1
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies
8-K
EX-99.1
RGEN
Repligen Corp.
21 Feb 24
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
7:47am
is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies
8-K
EX-99.2
qp3qi6roo2o0wr2if k2
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
8-K
EX-99.1
rvuyx5 p14q
31 Oct 23
Repligen Reports Third Quarter 2023 Financial Results
7:48am
8-K
EX-99.1
vnu4we2q
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
8-K
EX-99.2
av4dpkaoq1
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
EX-99.1
hjbwifyh 8a9mmw0ivdi
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
EX-99.1
wqer356drk
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
EX-99.1
93kg908 al
2 Aug 23
Repligen Reports Second Quarter 2023 Financial Results
7:54am
8-K
EX-99.1
mt8o81
2 May 23
Repligen Reports First Quarter 2023 Financial Results
7:48am
8-K
EX-99.1
djap4n9eb3jd5mash1
1 Nov 22
Repligen Reports Third Quarter 2022 Financial Results
7:54am